Clinical Trial Update: Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ACH-0143102 plus ribavirin for safety, tolerability, and antiviral activity in treatment-naive genotype 1b hepatitis C virus i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ACH-0143102
• Ribavirin (ribavirin)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Chronic Hepatitis C Infection | Phase 1 | Status: COMPLETED | Results posted: 2014-10-03